At Flagship Biosciences, our IHC services deliver high-quality, tissue-based biomarker insights to support preclinical and clinical research programs. With extensive experience in oncology, immunology, and rare diseases, we offer expert-guided assay development, optimization, and quantitative analysis—all designed to provide meaningful results you can trust.

We provide comprehensive IHC and IF assay development services, from selecting high-quality antibodies to choosing the appropriate platforms, control tissues, and experimental conditions to achieve optimal results. Whether you’re seeking a fit-for-purpose assay or full clinical validation, our expert team will help determine the necessary level of assay development.

At Flagship Biosciences, our IHC services deliver high-quality, tissue-based biomarker insights to support preclinical and clinical research programs. With extensive experience in oncology, immunology, and rare diseases, we offer expert-guided assay development, optimization, and quantitative analysis—all designed to provide meaningful results you can trust. 

We provide comprehensive IHC and IF assay development services, from selecting high-quality antibodies to choosing the appropriate platforms, control tissues, and experimental conditions to achieve optimal results. Whether you’re seeking a fit-for-purpose assay or full clinical validation, our expert team will help determine the necessary level of assay development.